| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2430281C Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence |
| 08/25/2009 | CA2426936C Oral preparation containing seaweed for reduction of plaque and calculus |
| 08/20/2009 | WO2009102945A2 Method for treating stress urinary incontinence and symptomatic pelvic relaxation |
| 08/20/2009 | WO2009101940A1 Tablet having improved elution properties |
| 08/20/2009 | WO2009101182A1 Use of etonogestrel for benign prostate hyperplasia (bph). |
| 08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists |
| 08/20/2009 | US20090209484 Preventive and/or therapeutic agent for calcipenia |
| 08/20/2009 | US20090208595 Extract of plant Dendrobii caulis and preparing process thereof |
| 08/20/2009 | CA2715475A1 Method for treating stress urinary incontinence and symptomatic pelvic relaxation |
| 08/20/2009 | CA2714524A1 Tablet having improved elution properties |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090312A1 (S,S) reboxetine for treating attention deficit disorder |
| 08/19/2009 | EP2089361A2 Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1675603B1 Use of probiotic bacteria in the treatment of infection |
| 08/19/2009 | EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 08/19/2009 | CN101511799A Cyclic amine compound |
| 08/19/2009 | CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/19/2009 | CN101507809A Shanhui kidney invigorating slurry |
| 08/19/2009 | CN101507776A Traditional Chinese medicine preparation for treating kidney deficiency, waist and knees soreness and preparation method thereof |
| 08/19/2009 | CN101507760A Medicine composite for treating kidney disease |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528216C Chinese medicinal pill with date for treating liver and kidney diseases |
| 08/19/2009 | CN100528186C Process for preparing Chinese medicine compound injection for treating chronic renal failure and use |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | US7575740 Applying to the tissue formulation comprising first precursor component second precursor component comprises electrophilic component which crosslink at physiological temperatures over a period of time following application |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2409379C Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/13/2009 | WO2009099650A2 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098136A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009098135A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009098134A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence |
| 08/13/2009 | WO2009098133A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | WO2009077993A3 Treatment of interstitial cystitis |
| 08/13/2009 | WO2009052972A3 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 08/13/2009 | US20090203792 Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203626 Pediatric Amino Acid Solution for Parenteral Nutrition |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2713438A1 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | CA2711871A1 N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 a adrenergic partial agonist for the treatment of incontinence |
| 08/13/2009 | CA2711726A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/13/2009 | CA2711724A1 Novel imidazolinylmethyl aryl sulfonamides |
| 08/12/2009 | EP2088148A2 "Process for the preparation of solifenacin" |
| 08/12/2009 | EP2087903A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 08/12/2009 | EP2087892A2 (S,S) reboxetine for treating age associated learning and mental disorders |
| 08/12/2009 | EP2087890A1 Sustained release preparation for tissue regeneration therapy |
| 08/12/2009 | EP2087888A1 Adenosine a1 receptor antagonists for the treatment of alkalosis |
| 08/12/2009 | EP2086535A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1347753B3 Topical composition and method for treating urinary stress incontinence |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP1274319B1 Compositions and methods for improving vascular health |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | CN101506221A Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
| 08/12/2009 | CN101506210A 2-phenoxy pyrimidinone analogues |
| 08/12/2009 | CN101505766A Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 08/12/2009 | CN101502630A Method for measuring fingerprint of 'Fuyankang' tablet |
| 08/12/2009 | CN101502619A Chinese medicine for treating chronic renal failure |
| 08/12/2009 | CN101502502A Medicament composition for preventing and treating ischemia-reperfusion injury of kidney |
| 08/12/2009 | CN101502352A Multifunctional shoe pad and preparation method thereof |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100526277C Method for the treatment or prevention of lower urinary tract symptoms |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525821C Chinese medicine for treating bed-wetting disease and its production |
| 08/12/2009 | CN100525820C Medicine for treating prostate disease |
| 08/12/2009 | CN100525816C Herb medicine composition contg. Touhualiao (polygonaceae), preparation method and use thereof |
| 08/12/2009 | CN100525773C Injectable azithromycin freeze-dried powder, and its preparation method |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/11/2009 | US7572815 Amide derivative |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |